These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8637715)

  • 41. Inhibition of cancer cell growth by all-trans retinoic acid and its analog N-(4-hydroxyphenyl) retinamide: a possible mechanism of action via regulation of retinoid receptors expression.
    Liu G; Wu M; Levi G; Ferrari N
    Int J Cancer; 1998 Oct; 78(2):248-54. PubMed ID: 9754659
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A histone deacetylase inhibitor potentiates retinoid receptor action in embryonal carcinoma cells.
    Minucci S; Horn V; Bhattacharyya N; Russanova V; Ogryzko VV; Gabriele L; Howard BH; Ozato K
    Proc Natl Acad Sci U S A; 1997 Oct; 94(21):11295-300. PubMed ID: 9326603
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High retinoid X receptor expression in JEG-3 choriocarcinoma cells: involvement in cell function modulation by retinoids.
    Guibourdenche J; Roulier S; Rochette-Egly C; Evain-Brion D
    J Cell Physiol; 1998 Sep; 176(3):595-601. PubMed ID: 9699512
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Growth inhibition of cultured human gastric cancer cells by 9-cis-retinoic acid with induction of cdk inhibitor Waf1/Cip1/Sdi1/p21 protein.
    Naka K; Yokozaki H; Domen T; Hayashi K; Kuniyasu H; Yasui W; Lotan R; Tahara E
    Differentiation; 1997 Aug; 61(5):313-20. PubMed ID: 9342842
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mechanism of inhibition on activator protein-1 activity by all-trans retinoic acid in gastric cancer cells.
    Wu Q; Chen Z; Su W
    Chin Med J (Engl); 2000 Nov; 113(11):972-6. PubMed ID: 11776129
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Enhancement of Calu-1 human lung carcinoma cell growth in serum-free medium by retinoids: dependence on AP-1 activation, but not on retinoid response element activation.
    Wan H; Dawson MI; Hong WK; Lotan R
    Oncogene; 1997 Oct; 15(17):2109-18. PubMed ID: 9366527
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Analysis of the factors involved in the retinoic acid-induced differentiation of a retinoid-hypersensitive embryonal carcinoma cell mutant.
    Dietrich JM; McCormick PJ
    Exp Cell Res; 1994 Feb; 210(2):201-8. PubMed ID: 8299717
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Retinyl methyl ether down-regulates activator protein 1 transcriptional activation in breast cancer cells.
    Agadir A; Shealy YF; Hill DL; Zhang X
    Cancer Res; 1997 Aug; 57(16):3444-50. PubMed ID: 9270011
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Selective stimulation by ceramide of the expression of the alpha isoform of retinoic acid and retinoid X receptors in osteoblastic cells. A role of sphingosine 1-phosphate-mediated AP-1 in the ligand-dependent transcriptional activity of these receptors.
    Takeshita A; Watanabe A; Takada Y; Hanazawa S
    J Biol Chem; 2000 Oct; 275(41):32220-6. PubMed ID: 10915783
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vitamin D represses retinoic acid-dependent transactivation of the retinoic acid receptor-beta2 promoter: the AF-2 domain of the vitamin D receptor is required for transrepression.
    Jiménez-Lara AM; Aranda A
    Endocrinology; 1999 Jun; 140(6):2898-907. PubMed ID: 10342883
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Activity of retinoic acid receptor-gamma selectively binding retinoids alone and in combination with interferon-gamma in breast cancer cell lines.
    Widschwendter M; Daxenbichler G; Culig Z; Michel S; Zeimet AG; Mörtl MG; Widschwendter A; Marth C
    Int J Cancer; 1997 May; 71(3):497-504. PubMed ID: 9139890
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Growth suppression of transformed human bronchial epithelial cells by all-trans-retinoic acid occurs through specific retinoid receptors.
    Ahn MJ; Langenfeld J; Moasser MM; Rusch V; Dmitrovsky E
    Oncogene; 1995 Dec; 11(11):2357-64. PubMed ID: 8570187
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Functional specificity of the two retinoic acid receptor RAR and RXR families in myogenesis.
    Alric S; Froeschlé A; Piquemal D; Carnac G; Bonnieu A
    Oncogene; 1998 Jan; 16(2):273-82. PubMed ID: 9464546
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Growth inhibitory effect of retinoic acid in human breast cancer cells correlates with retinoic acid receptor alpha (RAR alpha) expression].
    Yu L; Shao Z; Cai S
    Zhonghua Zhong Liu Za Zhi; 1996 Nov; 18(6):429-32. PubMed ID: 9387294
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Receptor mechanisms mediating differentiation and proliferation effects of retinoids on neuroblastoma cells.
    Hewson QC; Lova PE; Malcolm AJ; Pearson AD; Redfern CP
    Neurosci Lett; 2000 Jan; 279(2):113-6. PubMed ID: 10674634
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of conformationally restricted synthetic retinoids on ovarian tumor cell growth.
    Wu S; Zhang D; Donigan A; Dawson MI; Soprano DR; Soprano KJ
    J Cell Biochem; 1998 Mar; 68(3):378-88. PubMed ID: 9518263
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differential effects of retinoic acid on growth and apoptosis in human colon cancer cell lines associated with the induction of retinoic acid receptor beta.
    Lee MO; Han SY; Jiang S; Park JH; Kim SJ
    Biochem Pharmacol; 2000 Mar; 59(5):485-96. PubMed ID: 10660115
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interaction of BAG-1 with retinoic acid receptor and its inhibition of retinoic acid-induced apoptosis in cancer cells.
    Liu R; Takayama S; Zheng Y; Froesch B; Chen GQ; Zhang X; Reed JC; Zhang XK
    J Biol Chem; 1998 Jul; 273(27):16985-92. PubMed ID: 9642262
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tumor suppressor function of a dominant negative retinoic acid receptor mutant.
    Crowe DL; Osaseri UE; Shuler CF
    Mol Carcinog; 1998 May; 22(1):26-33. PubMed ID: 9609098
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Human retinoic acid (RA) 4-hydroxylase (CYP26) is highly specific for all-trans-RA and can be induced through RA receptors in human breast and colon carcinoma cells.
    Sonneveld E; van den Brink CE; van der Leede BM; Schulkes RK; Petkovich M; van der Burg B; van der Saag PT
    Cell Growth Differ; 1998 Aug; 9(8):629-37. PubMed ID: 9716180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.